Patent ID: 6312722
Filing Date: 2001-11-06
Classification: A61K,A61P,Y10S

Abstract:
Two-stage pharmaceutical combined preparation for hormonal contraception containing at least 30 daily unit doses, which preparation, in its first stage, comprises as hormonal active ingredient a combination of an oestrogen preparation and, in a dose that is sufficient to inhibit ovulation, a gestagen preparation, in single stage form and, in the second stage comprises as the only hormonal active ingredient an ethynylestradiol in an amount from 0.01 to 0.015 mg in each daily unit dose, wherein the first stage comprises a minimum of 25 and a maximum of 77 daily discrete or continuous unit doses and the second stage comprises 5, 6 or 7 daily discrete or continuous unit doses, and wherein the total number of daily units is equal to the total number of days of the desired cycle of a minimum of 30 and a maximum of 84 days.